SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply

Lancet Gastroenterol Hepatol. 2021 Jul;6(7):523-524. doi: 10.1016/S2468-1253(21)00194-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Gastroenterology*
  • Humans
  • Inflammatory Bowel Diseases*
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines